NASDAQ:XERS

Xeris Pharmaceuticals Stock Predictions

etoro logo Buy XERS
*Your capital is at risk
$5.89
-0.110 (-1.83%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

XERS Prediction Chart

XERS Predictions History

Latest community submissions for XERS.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 20, 2025 $10.21 +10.50% $9.34 V 90.69% 1
Oct 17, 2025 $8.99 -1.64% $9.24 X 97.30% 0
Oct 17, 2025 $9.05 -1.02% $9.24 X 97.91% 0
Oct 17, 2025 Bullish $9.24 X 1
Oct 16, 2025 $9.12 -1.61% $9.14 V 99.79% 6
Oct 16, 2025 $9.18 -1.01% $9.14 V 99.60% 5
Oct 16, 2025 Bullish $9.14 V 0
Oct 6, 2025 $8.07 -1.56% $8.13 V 99.29% 4
Oct 6, 2025 $8.12 -0.97% $8.13 V 99.88% 6
Oct 6, 2025 $9.10 +10.98% $8.13 X 88.07% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for XERS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT XERIS PHARMACEUTICALS INC
Xeris Pharmaceuticals
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhi...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE